Last updated on April 17, 2014 at 13:47 EDT

STARsystem by Sanofi Canada Receives Digital Innovation Award

December 4, 2012

The web-based support platform for Canadians living with diabetes was
named one of the country’s best eHealth initiatives at the 3(rd) Annual Pharma Digital Awards

LAVAL, QC, Dec. 4, 2012 /CNW/ – Sanofi Canada’s web-based diabetes
support platform, STARsystem, shined brightly at this year’s Pharma
Digital Awards ceremony, hosted by eyeforpharma.  STARsystem was
honoured with the Digital Innovation Award — presented to a company
that has applied new products and/or technology in a creative manner
for the Canadian eHealth market.

Developed by Sanofi Canada in partnership with Tank, Nurun and Telus
Health, STARsystem was designed to address the unmet needs of Canadians
living with diabetes.  The unique site helps empower them by providing
tailored support and advice on five key areas:

        --  Monitoring
        --  Managing
        --  Eating
        --  Moving
        --  Feeling

“STARsystem is the result of a major collaboration of diabetes experts
from across the country. All of whom dedicated their time and expertise
to create a meaningful portal that is helping Canadians with diabetes,”
says Jon Fairest, President and CEO, Sanofi Canada.  “We’re so pleased
that STARsystem has been recognized by eyeforpharma and wish to extend
heartfelt congratulations to our STARsystem entourage as well as
everyone involved in its development.”

Through STARsystem, each user gets a personalized assessment that
directs them to tailored resources and provides a custom achievable
curriculum that guides them towards reaching their wellness goals.  A
personalized dashboard even helps track progress along the way.  It’s
like having a diabetes support team right in your pocket.  STARsystem
users also have access to health coaching, a team of healthcare
professionals who can provide support and additional information –
helping Canadians self-manage their condition.

STARsystem is free for iBGStar and BGStar monitor users and can be
accessed at www.STARsystem.Sanofi.ca.

eyeforpharma launched the Pharma Digital Awards in 2010 as a way of
recognizing the organizations and individuals responsible for producing
top eHealth initiatives in Canada and to showcase their work.  The
judging panel, comprised of some of Canada’s leading pharma and eHealth
visionaries, evaluated submissions based on both user experience
(quality of content, information architecture, interactivity and visual
design) and business alignment (strategy and impact/results).

The 2012 Pharma Digital Award winners receive a customized award and
have their company information and award-winning work promoted on the
eMarketing Canada Awards website.

About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops
and distributes therapeutic solutions focused on patients’ needs.
Sanofi has core strengths in the field of healthcare with seven growth
platforms: diabetes solutions, human vaccines, innovative drugs,
consumer healthcare, emerging markets, animal health and the new
Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York

Sanofi companies in Canada include Sanofi Canada (pharmaceuticals),
Sanofi Pasteur (vaccines), Sanofi Consumer Health (health and beauty),
Genzyme (rare diseases) and Merial (animal health). Together they
employ more than 1,700 people across the country. In 2011 Sanofi
companies invested $151.7 million in R&D in Canada, creating jobs,
business and opportunity throughout the country.

About eyeforpharma
eyeforpharma is the business intelligence division of a private company
headquartered in London, UK. eyeforpharma organizes more than 50 events
a year, globally.  These range from more intimate gatherings to major
events with hundreds of attendees.  Every conference is designed by
industry executives rather than by eyeforpharma, ensuring relevance,
wisdom and impartiality.  Currently there are 4 events run in Canada
including Digital Marketing, Market Access, Patient Communication and
Sales Excellence. For more information please visit www.eyeforpharma.com.


Source: PR Newswire